Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline–Update 2022
ML Gauci, C Aristei, JC Becker, A Blom… - European Journal of …, 2022 - Elsevier
Merkel cell carcinoma (MCC) is a rare skin cancer, accounting for less than 1% of all
cutaneous malignancies. It is found predominantly in white populations and risk factors …
cutaneous malignancies. It is found predominantly in white populations and risk factors …
[HTML][HTML] COVID-19 in cancer patients: risk, clinical features, and management
C Liu, Y Zhao, D Okwan-Duodu, R Basho… - Cancer biology & …, 2020 - ncbi.nlm.nih.gov
A novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has spread across the world, prompting the World Health Organization to declare the …
2) has spread across the world, prompting the World Health Organization to declare the …
The cutting-edge progress of immune-checkpoint blockade in lung cancer
F Zhou, M Qiao, C Zhou - Cellular & molecular immunology, 2021 - nature.com
Great advances in immune checkpoint blockade have resulted in a paradigm shift in patients
with lung cancer. Immune-checkpoint inhibitor (ICI) treatment, either as monotherapy or …
with lung cancer. Immune-checkpoint inhibitor (ICI) treatment, either as monotherapy or …
Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: A systematic review, meta-analysis, and expert opinion
HBV reactivation (HBVr) can be prevented by nucleos (t) ide analogues (NAs). We
conducted a systematic review and meta-analysis on the risk of HBVr associated with new …
conducted a systematic review and meta-analysis on the risk of HBVr associated with new …
Systemic treatment of HCC in special populations
L Rimassa, N Personeni, C Czauderna, F Foerster… - Journal of …, 2021 - Elsevier
Recent years have seen significant progress in the systemic treatment of hepatocellular
carcinoma (HCC), including the advent of immunotherapy. While several large phase III …
carcinoma (HCC), including the advent of immunotherapy. While several large phase III …
Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice
Systemic therapy for advanced hepatocellular carcinoma has expanded at an
unprecedented pace over the past 5 years. After tyrosine kinase inhibitors dominated the …
unprecedented pace over the past 5 years. After tyrosine kinase inhibitors dominated the …
Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy
Immune checkpoint inhibitors (ICIs) have revolutionised cancer treatment. However, immune-
related adverse events (irAEs) are a common side effect which can mimic infection …
related adverse events (irAEs) are a common side effect which can mimic infection …
[HTML][HTML] Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
TF Greten, GK Abou-Alfa, AL Cheng… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Patients with advanced hepatocellular carcinoma (HCC) have historically had few options
and faced extremely poor prognoses if their disease progressed after standard-of-care …
and faced extremely poor prognoses if their disease progressed after standard-of-care …
Cancer management during COVID-19 pandemic: is immune checkpoint inhibitors-based immunotherapy harmful or beneficial?
S Vivarelli, L Falzone, CM Grillo, G Scandurra, F Torino… - Cancers, 2020 - mdpi.com
The coronavirus disease 2019 (COVID-19) is currently representing a global health threat
especially for fragile individuals, such as cancer patients. It was demonstrated that cancer …
especially for fragile individuals, such as cancer patients. It was demonstrated that cancer …
Immune-checkpoint inhibitors from cancer to COVID-19: A promising avenue for the treatment of patients with COVID-19
S Vivarelli, L Falzone, F Torino… - International …, 2020 - spandidos-publications.com
The severe acute respiratory syndrome associated coronavirus-2 (SARS-CoV-2) poses a
threat to human life worldwide. Since early March, 2020, coronavirus disease 2019 (COVID …
threat to human life worldwide. Since early March, 2020, coronavirus disease 2019 (COVID …